Your medical cannabis journey simplified: find partnered dispensaries, explore pricing options, earn rewards, and get answers to FAQs, all in one spot.
April 14, 2023 08:30 am ETEstimated Read Time: 3 Minutes
Washington and Arizona are embracing psilocybin, the Chicago Cubs announced a canna-tastic partnership, and Maryland is getting ready to jump-start its recreational market.
Let’s dive into this week’s cannanews.
Washington and Arizona Make Psilocybin Moves
Psilocybin legalization has been a hot topic in capitol buildings all over the U.S. Most recently, Arizona and Washington have both made progress on psilocybin-related legislation.
Last week, the Washington State House committee approved a psilocybin research bill with a 23-8 vote. The research bill establishes a task force and advisory board to study the viability of legalizing psilocybin in the state.
A different version of the bill was introduced earlier this year with the intention of broadly legalizing psilocybin. Unfortunately, the legalization statute was removed as some representatives questioned the safety of psilocybin therapies.
Meanwhile, in Arizona, legislators are proposing a bill that would allocate $30 million toward psilocybin research. If signed, Arizona would become the first state to conduct state-funded medical studies on the therapeutic use of mushrooms.
Apply For Your Medical Marijuana Card Today
Veriheal has satisfied hundreds of thousands of patients nationwide
Get approved or your money back
Appointments available on-demand
Customer support available 24/7
The bill has received support from medical professionals all over the state—like Dr. Sue Sisley, president of the Scottsdale Research Institute. Sisley emphasized the importance of the bill, saying, “…We know that there’s millions of people around the globe that are actively utilizing psilocybin mushrooms to treat a variety of their own ailments. So we just want to understand how these mushrooms are working or not working.”
Chicago Cubs Announce CBD Drink Partnership
The Chicago Cubs have made canna-history. The team recently announced its new partnership with CBD company MYND DRINKS. This marks the first time an MLB team has partnered with a CBD company.
MYND DRINKS is Chicago-based and makes sparkling CBD drinks that promote wellness and stress reduction. The CBD drink will be marketed and sold at Wrigley Field, home of the Chicago Cubs. As part of the partnership launch, the Cubs are releasing a guided meditation on YouTube narrated by Cubs radio play-by-play announcer Pat Hughes.
What do you think of the Cubs’ new partnership? Would you try MYND DRINKS CBD beverage at a baseball game? Let us know in the comments!
Maryland Outlines Recreational Market
Maryland is ramping up to get its recreational cannabis market off the ground. Late last week, Maryland’s General Assembly met to establish the legal framework of the new market.
Starting from July 1, 2023, individuals aged 21 and above who possess valid identification will have the opportunity to purchase recreational marijuana without legal repercussions. All recreational cannabis sales will come with a 9% tax rate—one of the lowest in the nation. The hope is that the low tax rate will keep the illicit market at bay. This is different from other legal states, where high cannabis taxes are used to raise money for various initiatives.
Mexico-born and California-raised, Cesar is a Marketing Associate at Veriheal. When he’s not scouring social media for the latest internet drama, you can find him working on yet another collage project.
Incredibly intriguing. I am prescribed a literal slew of medications and I am not allowed to engage in the use of cannabis in any form or manner whatsoever. It’s ungodly demeaning for me as of all of my ailments are both physical and mental. I have worked on legal farms/purveyors of cannabis. I experienced a TBI (traumatic brain injury) so thus therein the doctors do not want me to engage in the use of this in any form or manner whatsoever. It’s ungodly aggravating and demeaning for me indefinitely.
Blunts: What are they exactly, and how do they affect your body? If you’re interested in smoking blunts—or already smoke them—this guide is for you. We’ll cover everything you need to know about this popular cannabis intake method, including how they’re made, how they differ from spliffs and joints, risks of use, and alternative intake…
“Stoned,” “high,” “tripping,” and “baked,” are all terms engrained in the cannabis community. These metaphorical descriptions contribute to how we perceive, interpret, and learn from the experiences produced by cannabis consumption. Cannabis experiences, of course, are unique and highly variable. Specific plant strains, the presence of other cannabinoids, different delivery methods, and a user’s individual…
Thanks to the growing wave of legalization, more consumers than ever can grow their own cannabis right at home. Growing essentials that used to be secretive are now bought and sold freely. This includes items, like grow tents, nutrients, LED lighting, HPS lighting, ventilation, and more. Keeping all these items straight is hard enough, but…
Skin diseases plague millions of individuals, inflicting both physical discomforts in addition to mental and social stress. Thankfully, there is no shortage of skin treatment options available on the market. That said, this established market may soon be in for a major shake-up if recent cannabis research is any indication. Traditionally, cannabis research focused on studying…
As more states move toward legalization, accurately detecting impaired driving is of the utmost importance. Field Sobriety Tests (FSTs) have long been the go-to method for law enforcement to assess driver impairment caused by substances like alcohol. However, a recent 2023 study published in JAMA Psychiatry raises serious questions about the accuracy of these tests…
We use our own as well as third party cookies to improve your site experience and the services we make available. You can learn more about our use of cookies in our Privacy Policy.
Content Disclamer
The statements made regarding cannabis products on this website have not been evaluated by the Food and Drug Administration (FDA). Cannabis is not an FDA-approved substance and is still illegal under federal law. The information provided on this website is intended for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It is not intended as medical advice and should not be considered as a substitute for advice from a healthcare professional. We strongly recommend that you consult with a physician or other qualified healthcare provider before using any cannabis products. The use of any information provided on this website is solely at your own risk.